| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5913372 | Blood Cells, Molecules, and Diseases | 2016 | 17 Pages |
Abstract
We propose that LDH elevation identifies HbSC patients with hemolysis, which could be a marker of endothelial dysfunction and end-organ vasculopathy. The use of this test as a marker of disease severity could complement the decisions taken during HbSC patient management.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Simone Cristina Olenscki Gilli, Stephany Oliveira Bastos, Bruno Deltreggia Benites, Fernando Ferreira Costa, Sara Teresinha Olalla Saad,